From a zero-landfill plant to the historic goal of a zero-landfill National Park system, experience over a decade of our enviromental ingenuity. Explore.
Interestingly, Abou-Elella et al (11) could not confirm that the clinical course of PMLBCL was distinct from diffuse large B-cell lymphoma (DLBCL). Treatment of the lymph node cancer called diffuse large B-cell lymphoma is all-or-nothing. Genes make potential target in lymph cancer. Despite this, indolent disease is typically incurable, with the most aggressive lymphoma subtype - diffuse large B-cell lymphoma having 5-year survival rates of -50%.
Diffuse large B-cell lymphoma (DLBCL) is a common type of non-Hodgkin lymphoma. It develops when the body makes abnormal B-lymphocytes â the lymphoma cells. (B-cell lymphocytes are white blood cells that fight infection). Sometimes lymphoma cells begin in other parts of the body.